Colleen Parent
Family Medicine · Albany, NYNPI 1821293598
Payments from drug & device makers
Across 121 payments — averaging $19.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$842
- Gilead$297
- Abbott$158
- Alkermes, Inc.$144
- Indivior Inc.$133
- Novo Nordisk$130
- plus $709 from 20 others
What the payments were for
- Food & beverage$2,414100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 49 | $842 |
| Gilead | 5 | $297 |
| Abbott | 8 | $158 |
| Alkermes, Inc. | 3 | $144 |
| Indivior Inc. | 6 | $133 |
| Novo Nordisk | 7 | $130 |
| Orexo US, Inc. | 5 | $99 |
| GSK | 6 | $88 |
| Boehringer Ingelheim | 3 | $54 |
| Johnson & Johnson | 3 | $50 |
| Arbor Pharmaceuticals, Inc. | 4 | $48 |
| Merck | 3 | $40 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $38 |
| AstraZeneca | 2 | $37 |
| Neurocrine Biosciences, Inc. | 2 | $36 |
| Amarin Pharma, Inc. | 2 | $34 |
| Lilly USA, LLC | 2 | $28 |
| Dermira, Inc. | 1 | $24 |
| Pfizer | 1 | $22 |
| Eisai Inc. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| IBSA Pharma Inc. | 1 | $16 |
| Amgen | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,414 in reported general payments places this provider in the 75th percentile of 4,321 family medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 102 | $11,467 |
| Topiramate | 11 | $82 |
| Clonidine Hcl | 21 | $60 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Albany
- Jose DavidAlbany$106K
- Matthew DavisRochester$76.6M
- Frank EderBinghamton$46.2M
- Suchet PatelEndwell$23.3M
- James WildGowanda$2.2M
- Michael FedericoEndwell$1.4M
- Donald BrautigamWestfield$1.3M
- Kimberly DesantisEndwell$1.1M
- Michael TugetmanHartsdale$1M
- Richard RuhOrchard Park$769K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.